Attention: This is the dev site

Log In

Forgot Password?
Create New Account

Loading... please wait

capitol hill report: AAN SUBMITS COMMENTS ON 2024 MEDICARE PHYSICIAN FEE SCHEDULE

September 11, 2023

Issue in Focus

On September 7, the AAN submitted comments in response to the 2024 Medicare Physician Fee Schedule (PFS) proposed rule. Every year, the Centers for Medicare and Medicaid Services (CMS) issues updates to payment policies and rates for physicians paid under Medicare. In response to the proposals issued by CMS in the PFS, the AAN develops detailed feedback for the agency to consider before changes are finalized and implemented. The proposed rule illustrates the importance of the AAN’s regulatory advocacy efforts on behalf of neurologists and their patients.

CMS is projecting that the overall impact of changes contained in the proposed rule will result in a one-percent increase in payments to neurology as a specialty broadly. Due to the phase-out of temporary relief measures contained in the Consolidated Appropriations Act of 2023 and statutory budget neutrality requirements, CMS is currently predicting a reduction in the Fee Schedule conversion factor of approximately 3.4 percent. The AAN will continue to work with legislators to offset the impacts of statutorily required cuts. The AAN is committed to payment reform efforts to promote a sustainable payment system, such as ensuring physicians receive an inflationary adjustment tied to the Medical Economic Index, and to working with regulators and legislators to ensure that CMS appropriately values the work done by neurologists.

The AAN’s comments focus on high-priority issue areas for neurologists including changes made impacting evaluation and management services, such as the proposed implementation of an add-on code to better account for the work associated with caring for complex patients and a proposed delay in implementation of changes impacting split (or shared) billing that will have detrimental impacts on team-based care. The AAN also provided feedback on changes to existing telehealth policies, such as the extension of critical regulatory flexibilities including continued coverage of audio-only services and waiving site restrictions through 2024, proposed modifications to the list of services on the Medicare Telehealth list, and continued flexibility relating to direct supervision of both staff and residents. In a significant win for AAN advocacy, the AAN is also highly encouraged that CMS is proposing to retire the appropriate use criteria program and rescind all implementing regulations. The AAN also provided the agency with robust feedback on the future of the Quality Payment Program and the need to ensure that reporting requirements are not overly burdensome.

 

Latest Advocacy News

The AAN Leads Advocacy Efforts to Support the Conrad 30 Program
The AAN sent letters in support of the Conrad State 30 and Physician Access Reauthorization Act (S.665/H.R.4942), legislation that would reauthorize and expand the Conrad 30 program, to bill leads in the House House (Reps. Schneider [D-IL], Bacon [R-NE], Valadao [R-CA]) and the Senate (Senators Klobuchar [D-MN] and Collins [R-ME]). The AAN is a leader on legislative efforts in support of the Conrad 30 program and worked closely with these offices to ensure that this legislation was reintroduced in the 118th Congress.

Congress Back in Session Starting September 12
Both chambers of Congress will be back in session starting September 12. Over the next month, both the House and the Senate will be working on passing all 12 appropriations bills. With a limited number of session days left before government funding expires on September 30, leadership is working on drafting a short-term continuing resolution to expire before December in order to encourage passage of all 12 bills.

 

What We're Reading

  • US Senate races ahead of House on spending bills, aims to avoid gov’t shutdown (Reuters)
  • After the pandemic ends, long COVID still needs congressional attention (Op-Ed, The Hill)
  • 5 Things to Know About the New Drug Pricing Negotiations (KFF Health News)